ANGELUCCI ADRIANO ET AL: "Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells" PROSTATE, vol. 59, no. 2, 1 May 2004 (2004-05-01), pages 157-166, XP002520067 ISSN: 0270-4137 (B1)

ANGELUCCI ADRIANO ET AL: "Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice" ENDOCRINE-RELATED CANCER, vol. 13, no. 1, March 2006 (2006-03), pages 197-210, XP008089426 ISSN: 1351-0088 (B1)

MIMEAULT MURIELLE ET AL: "Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells" MOLECULAR CANCER THERAPEUTICS, vol. 6, no. 3, March 2007 (2007-03), pages 967-978, XP008089359 ISSN: 1535-7163 (B1)

MIMEAULT MURIELLE ET AL: "Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide" INTERNATIONAL JOURNAL OF CANCER, vol. 120, no. 1, January 2007 (2007-01), pages 160-169, XP008089360 ISSN: 0020-7136 (B1)

NORMANNO N ET AL: "Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: Different mechanisms of action for a novel therapeutic application?" ENDOCRINE-RELATED CANCER 200603 GB, vol. 13, no. 1, March 2006 (2006-03), pages 3-6, XP002520066 ISSN: 1351-0088 (B1)

WO-A1-2006/052249 (B1)

SALZBERG MARC ET AL: "An open-label, noncomparative phase II trial to evaluate the efficacy and safety of docetaxel in combination with gefitinib in patients with hormone-refractory metastatic prostate cancer" ONKOLOGIE, vol. 30, no. 7, 2007, pages 355-360, XP008089357 ISSN: 0378-584X (B1)

SEE ET AL: "Bicalutamide 150 mg in Addition to Standard Care Delays Progression to Bone Metastases in Patients with Locally Advanced Prostate Cancer: Analyses From the Second Analysis of the Early Prostate Cancer Program" INTERNATIONAL JOURNAL OF RADIATION: ONCOLOGY BIOLOGY PHYSICS, PERGAMON PRESS, US, vol. 63, 1 October 2005 (2005-10-01), pages S286-S287, XP005083495 ISSN: 0360-3016 (B1)

SHAFFER ET AL.: "A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer" EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, PERGAMON, OXFORD, GB, vol. 3, no. 2, October 2005 (2005-10), page 419, XP005133559 ISSN: 1359-6349 (B1)

SOHA SALAMA EL SHEIKH ET AL: "PHOSPHORYLATION OF BOTH EGFR AND ERBB2 IS A RELIABLE PREDICTOR OF PROSTATE CANCER CELL PROLIFERATION IN REPONSE TO EGF" NEOPLASIA, DOYMA, BARCELONA, ES, vol. 6, no. 6, 1 November 2004 (2004-11-01), pages 846-853, XP008050753 ISSN: 0212-9787 (B1)

TOS A P DEI: "The biology of epidermal growth factor receptor and its value as a prognostic/predictive factor" INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, vol. 22, no. 1, Suppl. 4, January 2007 (2007-01), pages S3-S9, XP002520065 ISSN: 0393-6155 (B1)

ODA KANAE ET AL: "A comprehensive pathway map of epidermal growth factor receptor signaling ( ARTICLE NO.: 2005.0010)" MOLECULAR SYSTEMS BIOLOGY, [Online] vol. 1, no. 1, May 2005 (2005-05), XP002520068 ISSN: 1744-4292 Retrieved from the Internet: URL:http://www.nature.com/msb/journal/v1/n 1/pdf/msb4100014.pdf> (B1)